ATE424808T1 - Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva - Google Patents
Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektivaInfo
- Publication number
- ATE424808T1 ATE424808T1 AT01996371T AT01996371T ATE424808T1 AT E424808 T1 ATE424808 T1 AT E424808T1 AT 01996371 T AT01996371 T AT 01996371T AT 01996371 T AT01996371 T AT 01996371T AT E424808 T1 ATE424808 T1 AT E424808T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutically acceptable
- infectives
- pharmaceutical compositions
- compositions containing
- agent
- Prior art date
Links
- 229960005475 antiinfective agent Drugs 0.000 title abstract 4
- 239000003246 corticosteroid Substances 0.000 title abstract 3
- 230000002924 anti-infective effect Effects 0.000 title 1
- 229960001334 corticosteroids Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 3
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 3
- 239000004599 antimicrobial Substances 0.000 abstract 3
- 229940126575 aminoglycoside Drugs 0.000 abstract 2
- 229940000425 combination drug Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000010668 complexation reaction Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 1
- 150000007660 quinolones Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1018MU2000 | 2000-11-15 | ||
| IN1077MU2001 | 2001-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424808T1 true ATE424808T1 (de) | 2009-03-15 |
Family
ID=26324912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01996371T ATE424808T1 (de) | 2000-11-15 | 2001-11-12 | Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20040077562A1 (de) |
| EP (1) | EP1337237B1 (de) |
| AT (1) | ATE424808T1 (de) |
| AU (2) | AU2002216357B2 (de) |
| BR (1) | BR0115415A (de) |
| CA (1) | CA2428189A1 (de) |
| DE (1) | DE60137960D1 (de) |
| MX (1) | MXPA03004241A (de) |
| WO (1) | WO2002039993A2 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004069280A1 (en) * | 2003-02-06 | 2004-08-19 | Cipla Ltd | Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent |
| MXPA05008913A (es) * | 2003-02-21 | 2005-10-05 | Sun Pharmaceutical Ind Ltd | Formulacion oftalmica estable que contiene antibiotico y corticoesteroide. |
| WO2004103373A1 (ja) * | 2003-05-23 | 2004-12-02 | Santen Pharmaceutical Co.,Ltd. | キノロン系抗菌化合物を含有する点眼液 |
| US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| US20060141049A1 (en) * | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
| US20070224278A1 (en) * | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| BRPI0506983A (pt) | 2004-01-20 | 2007-07-03 | Allergan Inc | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico |
| DE602005026225D1 (de) * | 2004-03-12 | 2011-03-24 | Cipla Ltd | Sterilisationsprozess für Steroide |
| US8147865B2 (en) * | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
| US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
| US8372814B2 (en) | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| US8748402B2 (en) | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| CA2571554A1 (en) * | 2004-06-28 | 2006-01-19 | Alza Corporation | A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| US20060009498A1 (en) * | 2004-07-12 | 2006-01-12 | Allergan, Inc. | Ophthalmic compositions and methods for treating ophthalmic conditions |
| WO2006043965A1 (en) * | 2004-10-14 | 2006-04-27 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| US8668676B2 (en) * | 2006-06-19 | 2014-03-11 | Allergan, Inc. | Apparatus and methods for implanting particulate ocular implants |
| WO2008002117A1 (es) * | 2006-06-27 | 2008-01-03 | Jimenez Bayardo, Arturo | Solución oftálmica de ciprofloxacina y dexametasona |
| US20080097335A1 (en) * | 2006-08-04 | 2008-04-24 | Allergan, Inc. | Ocular implant delivery assemblies |
| KR20090111328A (ko) * | 2007-01-17 | 2009-10-26 | 데비렉스 아게 | 사이클로덱스트린 제형 |
| WO2008130211A1 (es) * | 2007-04-20 | 2008-10-30 | Serral, S.A. De C.V. | Solución dinámica, estequiométrica de soporte y de equilibrio inducido |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| US8545554B2 (en) * | 2009-01-16 | 2013-10-01 | Allergan, Inc. | Intraocular injector |
| IL310360A (en) * | 2016-11-29 | 2024-03-01 | Oculis Operations Sarl | Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery |
| AU2020298754B2 (en) | 2019-07-01 | 2025-06-26 | Oculis Operations Sàrl | Method for stabilizing the pH of an aqueous composition comprising a drug |
| WO2021250482A1 (en) | 2020-06-11 | 2021-12-16 | Sentiss Pharma Private Limited | Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4201189A (en) * | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| US5374432A (en) * | 1989-07-28 | 1994-12-20 | The Trustees Of Columbia University Of The City Of New York | Topical anti-infective ointment containing silver or silver salts and antibiotics |
| US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| US5540930A (en) * | 1993-10-25 | 1996-07-30 | Pharmos Corporation | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
| US5516808A (en) * | 1994-10-27 | 1996-05-14 | Sawaya; Assad S. | Topical cellulose pharmaceutical formulation |
| BR0014203A (pt) * | 1999-09-24 | 2002-05-21 | Alcon Inc | Formulações de suspensão tópicas contendo ciprofloxacina e dexametasona |
| US6824804B2 (en) * | 2001-09-27 | 2004-11-30 | Broyles Properties, Ltd. | Pecan processing method and system |
-
2001
- 2001-11-12 US US10/416,837 patent/US20040077562A1/en not_active Abandoned
- 2001-11-12 CA CA002428189A patent/CA2428189A1/en not_active Abandoned
- 2001-11-12 DE DE60137960T patent/DE60137960D1/de not_active Expired - Lifetime
- 2001-11-12 EP EP01996371A patent/EP1337237B1/de not_active Expired - Lifetime
- 2001-11-12 WO PCT/IN2001/000199 patent/WO2002039993A2/en not_active Ceased
- 2001-11-12 AT AT01996371T patent/ATE424808T1/de not_active IP Right Cessation
- 2001-11-12 BR BR0115415-0A patent/BR0115415A/pt not_active Application Discontinuation
- 2001-11-12 AU AU2002216357A patent/AU2002216357B2/en not_active Ceased
- 2001-11-12 AU AU1635702A patent/AU1635702A/xx active Pending
- 2001-11-12 MX MXPA03004241A patent/MXPA03004241A/es active IP Right Grant
-
2007
- 2007-06-28 US US11/770,357 patent/US20070248565A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002039993A2 (en) | 2002-05-23 |
| MXPA03004241A (es) | 2004-12-03 |
| EP1337237B1 (de) | 2009-03-11 |
| US20070248565A1 (en) | 2007-10-25 |
| WO2002039993A3 (en) | 2003-02-27 |
| AU2002216357B2 (en) | 2006-08-17 |
| CA2428189A1 (en) | 2002-05-23 |
| AU1635702A (en) | 2002-05-27 |
| EP1337237A2 (de) | 2003-08-27 |
| BR0115415A (pt) | 2003-09-09 |
| US20040077562A1 (en) | 2004-04-22 |
| DE60137960D1 (de) | 2009-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE424808T1 (de) | Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva | |
| AU2002243387A1 (en) | Pharmaceutical dosage form for oral administration of low molecular weight heparin | |
| ATE235895T1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| CY1118206T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη | |
| NO20032511D0 (no) | Farmasöytiske sammensetninger for oral tilförsel av farmakologisk aktive midler | |
| CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
| TW200500098A (en) | Methods and dosage forms for increasing solubility of drug compositions for controlled delivery | |
| CO5560580A2 (es) | Formulaciones de sucralosa para disumular sabores desagradables | |
| TR200102226T2 (tr) | Formoterol ve bir tiotropium tuzunun kombinasyonları | |
| DK0991407T3 (da) | Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer | |
| DE60111743D1 (de) | Arzneimittelkombinationen zur restenose-prävention | |
| AU2002239282A1 (en) | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof | |
| CY1105953T1 (el) | Συνθεσεις για απελευθερωση συνδυασμων φαρμακων | |
| WO2002013873A3 (en) | P97-active agent conjugates and their methods of use | |
| CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
| CY1105065T1 (el) | Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση | |
| BR0316279A (pt) | Compostos orgânicos | |
| DK1073467T3 (da) | Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin D | |
| LT2001119A (en) | Pharmaceutical formulations comprising intranasal morphine and use thereof | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| ATE359777T1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| ATE289801T1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
| ATE357928T1 (de) | Pharmazeutische zusammensetzung für thrombinpeptidderivaten | |
| CA2352915A1 (en) | Pharmaceutical compositions containing mupirocin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |